entertainment -WSS

entertainment

author：explore 2025-09-29 10:40:41 - browse：84342

Illustration of a human hand beneath a projection of digital files to visualize humans' role in AI technology — Adobe

Developers of artificial intelligence models slowly making their way into medicine have long parried ethical concerns with assertions that clinical staff must review tech’s suggestions before they are acted on. That “human in the loop” is meant to be a backstop preventing potential medical errors conjured up by a flawed algorithm from harming patients.

And yet, industry experts warn that there’s no standard way to keep humans in the loop, giving technology vendors significant latitude to market their AI-powered products as helpful professional tools rather than as autonomous decision-makers.

Health record giant Epic is piloting a generative AI feature that drafts responses to patients’ email queries, but clinical staff must review the suggestions before they are sent out, the company has said. A flurry of AI-guided ambient documentation startups can rapidly transcribe and summarize patient visits and populate patients’ medical charts, but they require doctors and nurses to OK the generated entries first. Products predicting health risks — like overdose or sepsis — show up as flags in medical record software, and it’s up to clinicians to act on it.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： New clues to why women have higher risk of autoimmune disorders

focus

WSS

AstraZeneca challenges Medicare drug negotiation program

In science, is the line between industry and academia shifting?

As pharma fights Medicare drug negotiation, hospitals, docs silent

10 reasons why health care startups fail

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

How to make Best Hospitals ratings actually useful for patients

focus

entertainment

explore

The cancer drug shortage isn’t new — and neither are the solutions

Australia’s approach to dialysis celebrates life

The high cost of giving birth even with insurance

Biogen walks away from Aduhelm, years after polarizing approval

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As pharma fights Medicare drug negotiation, hospitals, docs silent

Walensky prepares to leave CDC — and Congress — behind

Departing Stanford president retracts two papers

Continuity nursing helped my family in our darkest PICU moments

As pharma fights Medicare drug negotiation, hospitals, docs silent

focus

Humana’s losses in Medicare Advantage tank its stock

Departing Stanford president retracts two papers

Health Care Service Corp to buy Cigna Medicare Advantage plans

FTC sues over Novant Health acquisition of two N.C. hospitals

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Boston competes with Raleigh

entertainment

explore

focus

focus